Stromal Annexin A2 expression is predictive of decreased survival in pancreatic cancer.

Murphy, Adrian G; Foley, Kelly; Rucki, Agnieszka A; Xia, Tao; Jaffee, Elizabeth M; Huang, Chiung-Yu; Zheng, Lei

Murphy, Adrian G; Foley, Kelly; Rucki, Agnieszka A; Xia, Tao; Jaffee, Elizabeth M; Huang, Chiung-Yu; Zheng, Lei.

Afiliação

Murphy AG; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Foley K; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Rucki AA; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Xia T; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Jaffee EM; Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Huang CY; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Zheng L; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Oncotarget ; 8(63): 106405-106414, 2017 Dec 05.

Article em En | MEDLINE | ID: mdl-29290958

Palavras-chave

Annexin A2; pancreatic cancer; stroma; tumor microenvironment

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google